Latham & Watkins represented the underwriters in the offering.Pyxis Oncology, Inc., a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat…
Pyxis Oncology’s $168 Million Upsized Initial Public Offering
